In a recent work, TBK1 was shown to be highly expressed in lung, breast and colon cancers, and subjects with tumors that highly express TBK1 have poor responsiveness to tamoxifen treatment and a high potential for relapse [35]. This evidence concerns the gene TBK1 and malignant colon neoplasm.